Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-04

Clinical Trial Update: Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis [NA]

View source ↗

Summary

This document reports on a completed clinical trial evaluating cefotaxime resistance in the treatment of spontaneous bacterial peritonitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefotaxime (Cefotaxime)

Snippet

Sponsor: Dr Ahmed Ali Elbaz | Conditions: Spontaneous Bacterial Peritonitis | NA | Status: COMPLETED